Eventide Asset Management - ACELRX PHARMACEUTICALS INC ownership

ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 76 filers reported holding ACELRX PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 2.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of ACELRX PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$938,000
+22.6%
139,4000.0%0.10%
-4.7%
Q3 2014$765,000
-46.5%
139,4000.0%0.11%
-44.8%
Q2 2014$1,429,000
-14.6%
139,4000.0%0.19%
-25.4%
Q1 2014$1,674,000
+179.5%
139,400
+163.0%
0.26%
+40.5%
Q4 2013$599,00053,0000.18%
Other shareholders
ACELRX PHARMACEUTICALS INC shareholders Q4 2014
NameSharesValueWeighting ↓
Perceptive Advisors 6,574,060$27,874,0001.68%
SENZAR ASSET MANAGEMENT, LLC 798,381$3,385,0000.58%
Cormorant Asset Management, LP 850,000$3,604,0000.48%
Palo Alto Investors LP 2,135,739$9,056,0000.40%
Opus Point Partners Management, LLC 99,959$424,0000.34%
Granahan Investment Management 1,582,237$6,709,0000.19%
Joel Isaacson & Co., LLC 70,660$300,0000.08%
MARINER INVESTMENT GROUP LLC 59,700$253,0000.06%
MYCIO WEALTH PARTNERS, LLC 75,000$318,0000.06%
Cornerstone Capital, Inc. 59,200$251,0000.06%
View complete list of ACELRX PHARMACEUTICALS INC shareholders